Mark D. Pihlstrom

Mergers & Acquisitions

Mark represents buyers and sellers, and strategic and private equity, in mergers, stock- and asset-based transactions, carve-outs, and leveraged buyouts ranging from less than $10 million to more than $1 billion.

Clients he has advised in significant M&A transactions include APi Group, General Mills, Hormel, Mortenson, Proto Labs, Thomson Reuters, UnitedHealth Group, W. L. Gore & Associates, and Zimmer Biomet.

Section 363 Bankruptcy Acquisitions

Mark also represents purchasers in Section 363 bankruptcy sales. Clients have included Baxter International and Wayzata Investment Partners.

Emerging Companies & Venture Capital

Mark represents emerging companies, venture capital funds, and corporate venture arms in private placements of debt and equity securities. He advises clients from startups to public companies on corporate matters, including corporate governance, contract preparation and negotiation, financing issues, restructurings, and ongoing strategic and transactional matters.

On significant venture capital investments, Mark has worked with clients including 3M Company, General Mills, Hormel, Otsuka, Target, Truehelm, UnitedHealth Group, W. L. Gore & Associates, Xcel Energy, and Zimmer Biomet.

Mark leads Faegre Drinker's venture capital practice.